BRD4 and cancer: Pioneering studies have revealed that BRD4 is frequently overexpressed in multiple cancers including HNSCC [19, 38–40], and promotes tumorigenesis, cancer cell proliferation, metastasis and drug resistance by elevating the expression of cancer drivers [41–44].